Tria Preps 510(k) For OTC Skin Rejuvenating Laser, Files For IPO

Aesthetic device maker plans to file a 510(k) this year for its over-the-counter, non-ablative laser to treat facial wrinkles, supported in part by proceeds from an initial public stock offering worth up to $86.3 million.

TRIA Beauty Inc. hopes to enter the anti-aging aesthetic treatment market later this year with its over-the-counter Skin Rejuvenating Laser, supported in part with the proceeds of an initial public stock offering worth up to $86.3 million.

The firm plans to file a 510(k) this year for OTC use of the fractional, non-ablative technology to treat periorbital...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Strategy

More from Business